Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Spectral AI Inc. (MDAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: MDAI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Year Target Price $4.79
Year Target Price $4.79
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -52.13% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 54.58M USD | Price to earnings Ratio - | 1Y Target Price 4.79 |
Price to earnings Ratio - | 1Y Target Price 4.79 | ||
Volume (30-day avg) - | Beta 0.7 | 52 Weeks Range 0.82 - 3.25 | Updated Date 06/29/2025 |
52 Weeks Range 0.82 - 3.25 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.55 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.75% | Operating Margin (TTM) -13.36% |
Management Effectiveness
Return on Assets (TTM) -18.42% | Return on Equity (TTM) -2308.32% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 50277740 | Price to Sales(TTM) 1.82 |
Enterprise Value 50277740 | Price to Sales(TTM) 1.82 | ||
Enterprise Value to Revenue 1.68 | Enterprise Value to EBITDA -3.41 | Shares Outstanding 25747500 | Shares Floating 17924135 |
Shares Outstanding 25747500 | Shares Floating 17924135 | ||
Percent Insiders 30.56 | Percent Institutions 13.93 |
Analyst Ratings
Rating 4.67 | Target Price 4.79 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Spectral AI Inc.
Company Overview
History and Background
Spectral AI, Inc. was founded in 2008. The company is focused on developing and commercializing diagnostic imaging solutions for assessing burn wounds and other medical conditions.
Core Business Areas
- DeepView System: Spectral AI's core product, the DeepView System, utilizes proprietary spectral imaging technology and AI algorithms to assess burn wound severity and predict healing outcomes. This allows clinicians to make more informed decisions about treatment and resource allocation.
Leadership and Structure
The company is led by its CEO, and has a structured organization focused on research, development, sales, and marketing.
Top Products and Market Share
Key Offerings
- DeepView System: The DeepView System is Spectral AI's primary product. It utilizes spectral imaging and AI to assess burn wounds. Market share is currently small but growing, with increasing adoption in burn centers. Competitors include companies offering traditional burn assessment methods and other advanced imaging technologies.
Market Dynamics
Industry Overview
The medical device industry, specifically the burn care market, is driven by the need for improved diagnostic tools and treatment strategies. The industry is competitive and subject to regulatory oversight.
Positioning
Spectral AI is positioned as an innovator in burn wound assessment, offering a technology-driven solution that aims to improve patient outcomes and reduce healthcare costs. Its competitive advantage lies in its unique spectral imaging and AI technology.
Total Addressable Market (TAM)
The global burn care market is estimated to be several billion dollars. Spectral AI is positioned to capture a significant share of this market with its DeepView System.
Upturn SWOT Analysis
Strengths
- Proprietary spectral imaging technology
- AI-driven diagnostic capabilities
- Potential to improve patient outcomes
- Strong intellectual property protection
Weaknesses
- Limited market adoption to date
- Reliance on single product
- Need for further clinical validation
- Requires capital for market expansion
Opportunities
- Expansion into other wound care applications
- Partnerships with healthcare providers and distributors
- Increased adoption of AI in healthcare
- Growing demand for improved burn care solutions
Threats
- Competition from established medical device companies
- Regulatory hurdles
- Technological obsolescence
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- Mallinckrodt (MNK)
- Integra LifeSciences (IART)
- Smith & Nephew (SNN)
Competitive Landscape
Spectral AI has advantages in its technology, but smaller scale and brand recognition compared to major competitors.
Growth Trajectory and Initiatives
Historical Growth: Insufficient data for meaningful analysis.
Future Projections: Insufficient data for meaningful analysis.
Recent Initiatives: Recent initiatives may include clinical studies, product development efforts, and market expansion activities.
Summary
Spectral AI is a developing company with innovative burn assessment technology that has the potential to improve outcomes. The company needs to gain market acceptance and scale its operations. Key areas for Spectral AI to watch out for are competition, reimbursement, and regulatory approval. The growth of Spectral AI would depend on wider usage and adoption from burn centers. More importantly, they must validate their product so burn centers will consider the DeepView System.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate. Financial data should not be considered accurate as this is a private company.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Spectral AI Inc.
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2021-04-06 | Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO Mr. Wensheng Fan | ||
Sector Healthcare | Industry Medical Devices | Full time employees 78 | Website https://www.spectral-ai.com |
Full time employees 78 | Website https://www.spectral-ai.com | ||
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed decision regarding the treatment of the patient's wounds. The company's system also includes MSI imaging technology, a proprietary multi-spectral optics and sensors, capturing injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.